Thus, increased serum orexin A levels in acute ischemic stroke (AIS) patients might induce a higher risk of poststroke insomnia, which is detrimental to neurological recovery based on previous studies (Ho et al., 2021; Suh et al., 2016). Here, HCRT is linked to insomnia measurement.